Nifty
Sensex
:
:
24219.05
77369.11
-32.95 (-0.14%)
-171.72 (-0.22%)

Miscellaneous

Rating :
66/99

BSE: 506414 | NSE: FERMENTA

478.35
21-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  465.15
  •  481
  •  456.55
  •  460.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  92282
  •  43562748.3
  •  580.45
  •  248.85

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,407.39
  • 23.27
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,474.93
  • 0.78%
  • 3.41

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 64.09%
  • 1.23%
  • 28.33%
  • FII
  • DII
  • Others
  • 0.13%
  • 0.00%
  • 6.22%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.34
  • 5.68
  • 16.11

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.78
  • 10.16
  • 29.34

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 35.95
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.24
  • 9.90
  • 8.84

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.54
  • 2.16
  • 2.46

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.87
  • 16.68
  • 16.73

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
121.82
136.26
-10.60%
121.58
139.85
-13.06%
137.36
156.47
-12.21%
130.22
95.03
37.03%
Expenses
103.77
108.03
-3.94%
101.58
102.91
-1.29%
112.40
103.20
8.91%
103.59
76.25
35.86%
EBITDA
18.05
28.23
-36.06%
20.00
36.94
-45.86%
24.96
53.27
-53.14%
26.64
18.78
41.85%
EBIDTM
14.82%
20.72%
16.45%
26.42%
18.17%
34.05%
20.45%
19.76%
Other Income
4.37
8.77
-50.17%
5.06
3.89
30.08%
3.12
2.23
39.91%
5.43
2.88
88.54%
Interest
2.54
3.10
-18.06%
2.82
2.99
-5.69%
3.04
4.08
-25.49%
2.58
3.69
-30.08%
Depreciation
5.20
5.81
-10.50%
5.11
5.87
-12.95%
5.37
6.08
-11.68%
5.40
6.15
-12.20%
PBT
14.69
28.09
-47.70%
26.21
31.98
-18.04%
17.48
45.34
-61.45%
24.08
11.82
103.72%
Tax
5.16
6.48
-20.37%
7.61
-1.34
-
5.46
7.45
-26.71%
6.05
0.70
764.29%
PAT
9.53
21.60
-55.88%
18.60
33.32
-44.18%
12.02
37.89
-68.28%
18.03
11.12
62.14%
PATM
7.82%
15.85%
15.30%
23.83%
8.75%
24.21%
13.85%
11.70%
EPS
3.40
7.49
-54.61%
6.69
11.79
-43.26%
4.39
12.66
-65.32%
6.49
3.92
65.56%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
510.98
525.43
469.48
335.66
349.94
398.52
377.29
292.95
404.67
302.67
164.13
Net Sales Growth
-3.15%
11.92%
39.87%
-4.08%
-12.19%
5.63%
28.79%
-27.61%
33.70%
84.41%
 
Cost Of Goods Sold
181.95
191.93
158.45
130.13
153.55
153.15
134.37
79.02
92.26
80.41
68.43
Gross Profit
329.03
333.50
311.03
205.52
196.39
245.36
242.92
213.92
312.42
222.26
95.70
GP Margin
64.39%
63.47%
66.25%
61.23%
56.12%
61.57%
64.39%
73.02%
77.20%
73.43%
58.31%
Total Expenditure
421.34
424.47
358.98
307.77
331.75
336.29
294.71
228.64
269.35
211.54
152.17
Power & Fuel Cost
-
29.13
27.23
19.78
18.24
20.35
14.23
12.74
13.88
11.11
9.97
% Of Sales
-
5.54%
5.80%
5.89%
5.21%
5.11%
3.77%
4.35%
3.43%
3.67%
6.07%
Employee Cost
-
82.59
65.10
58.55
58.00
62.97
58.22
50.03
53.18
39.83
30.84
% Of Sales
-
15.72%
13.87%
17.44%
16.57%
15.80%
15.43%
17.08%
13.14%
13.16%
18.79%
Manufacturing Exp.
-
32.85
35.58
36.56
32.66
37.22
31.08
21.62
27.60
26.64
17.04
% Of Sales
-
6.25%
7.58%
10.89%
9.33%
9.34%
8.24%
7.38%
6.82%
8.80%
10.38%
General & Admin Exp.
-
55.74
46.78
46.09
46.09
39.95
29.05
33.12
27.57
15.80
13.19
% Of Sales
-
10.61%
9.96%
13.73%
13.17%
10.02%
7.70%
11.31%
6.81%
5.22%
8.04%
Selling & Distn. Exp.
-
23.70
17.47
11.36
13.97
17.06
19.13
23.38
31.40
26.90
5.47
% Of Sales
-
4.51%
3.72%
3.38%
3.99%
4.28%
5.07%
7.98%
7.76%
8.89%
3.33%
Miscellaneous Exp.
-
8.54
8.37
5.30
9.24
5.58
8.63
8.73
23.47
10.84
5.47
% Of Sales
-
1.63%
1.78%
1.58%
2.64%
1.40%
2.29%
2.98%
5.80%
3.58%
4.41%
EBITDA
89.65
100.96
110.50
27.89
18.19
62.23
82.58
64.31
135.32
91.13
11.96
EBITDA Margin
17.54%
19.21%
23.54%
8.31%
5.20%
15.62%
21.89%
21.95%
33.44%
30.11%
7.29%
Other Income
17.98
22.39
11.82
11.81
8.60
8.25
8.37
14.20
26.50
10.83
2.78
Interest
10.98
12.66
14.89
17.43
21.37
17.98
19.00
20.09
21.23
13.63
9.96
Depreciation
21.08
21.70
24.22
24.72
28.25
25.56
20.31
15.00
11.89
12.36
10.31
PBT
82.46
88.98
83.21
-2.45
-22.83
26.94
51.63
43.42
128.71
75.97
-5.53
Tax
24.28
25.61
6.80
14.14
1.83
11.88
9.10
-16.10
10.80
21.13
2.70
Tax Rate
29.44%
26.72%
8.17%
-143.12%
-3.57%
44.10%
17.63%
-37.08%
8.39%
27.81%
-48.82%
PAT
58.18
71.76
76.86
-23.06
-51.07
15.45
45.51
59.53
117.88
42.21
-11.03
PAT before Minority Interest
60.49
70.25
76.40
-24.01
-53.13
15.06
42.53
59.52
117.90
54.84
-8.23
Minority Interest
2.31
1.51
0.46
0.95
2.06
0.39
2.98
0.01
-0.02
-12.63
-2.80
PAT Margin
11.39%
13.66%
16.37%
-6.87%
-14.59%
3.88%
12.06%
20.32%
29.13%
13.95%
-6.72%
PAT Growth
-44.02%
-6.64%
-
-
-
-66.05%
-23.55%
-49.50%
179.27%
-
 
EPS
19.79
24.41
26.14
-7.84
-17.37
5.26
15.48
20.25
40.10
14.36
-3.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
406.21
362.67
288.86
315.31
372.13
360.59
309.44
250.55
124.45
144.40
Share Capital
14.34
14.58
14.44
14.43
14.42
14.42
14.42
4.59
2.29
2.29
Total Reserves
388.66
347.79
261.69
287.63
343.02
334.17
288.94
245.21
122.16
142.11
Non-Current Liabilities
20.26
29.24
77.03
97.43
154.05
131.41
71.52
125.39
145.65
48.11
Secured Loans
7.90
15.05
42.54
83.59
114.68
110.44
101.79
135.21
135.37
40.32
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
10.74
21.61
14.97
20.08
67.43
58.77
4.06
6.31
2.73
2.67
Current Liabilities
208.77
245.20
194.07
229.77
227.85
230.09
194.60
155.98
103.56
86.16
Trade Payables
77.15
77.49
64.90
45.79
64.58
62.14
56.33
42.72
40.09
27.49
Other Current Liabilities
37.27
47.84
39.61
58.53
43.72
49.90
33.12
47.42
29.38
20.79
Short Term Borrowings
91.50
81.24
67.34
101.46
97.47
96.30
104.33
60.21
29.86
37.13
Short Term Provisions
2.85
38.63
22.22
23.98
22.07
21.75
0.81
5.63
4.23
0.75
Total Liabilities
629.57
632.95
556.26
639.76
753.35
721.79
575.57
531.94
384.64
307.14
Net Block
216.96
223.37
263.13
238.25
231.31
262.93
128.89
103.73
96.88
89.81
Gross Block
382.34
367.61
387.06
338.52
308.92
330.73
166.48
128.99
114.18
103.03
Accumulated Depreciation
165.38
144.25
123.93
100.27
77.61
67.80
37.59
25.25
17.30
13.21
Non Current Assets
241.56
264.40
293.70
365.69
418.61
391.42
291.56
226.13
202.38
202.88
Capital Work in Progress
13.11
15.91
1.62
45.02
34.56
56.91
70.77
21.58
3.50
5.49
Non Current Investment
0.42
0.49
0.43
0.37
0.29
0.25
71.52
74.41
1.32
7.93
Long Term Loans & Adv.
6.21
19.58
21.05
29.33
81.35
70.47
19.60
18.64
6.80
4.51
Other Non Current Assets
1.78
1.88
2.07
24.01
3.82
0.86
0.78
7.77
13.39
13.31
Current Assets
388.02
368.55
262.57
274.07
334.74
330.38
284.01
295.61
182.27
104.26
Current Investments
0.00
0.00
0.00
2.78
0.00
0.00
0.00
1.15
1.06
1.00
Inventories
152.54
123.65
87.38
130.14
159.48
162.27
128.58
87.67
51.18
38.91
Sundry Debtors
111.59
95.23
69.83
41.65
87.09
68.01
69.77
65.54
68.72
44.57
Cash & Bank
41.34
71.70
59.83
58.33
33.61
44.53
33.11
91.13
32.66
2.49
Other Current Assets
82.55
18.06
6.55
4.08
54.57
55.56
52.55
50.12
28.65
17.28
Short Term Loans & Adv.
75.16
59.92
38.97
37.09
43.32
42.69
43.41
31.14
18.31
12.90
Net Current Assets
179.25
123.36
68.49
44.30
106.90
100.29
89.42
139.63
78.71
18.10
Total Assets
629.58
632.95
556.27
639.76
753.35
721.80
575.57
531.93
384.65
307.14

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
92.83
40.90
105.35
116.11
43.44
62.60
34.46
90.34
59.26
1.91
PBT
95.86
83.21
-9.87
-51.31
26.94
51.63
43.42
128.71
75.97
-5.53
Adjustment
21.80
38.83
81.50
119.25
43.18
39.61
34.01
31.05
27.02
24.10
Changes in Working Capital
-8.41
-78.36
32.70
44.95
-17.38
-15.12
-29.03
-36.56
-25.46
-14.42
Cash after chg. in Working capital
109.25
43.67
104.33
112.90
52.75
76.12
48.40
123.20
77.54
4.16
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-16.42
-2.77
1.02
3.21
-9.31
-13.52
-13.94
-32.86
-18.28
-2.25
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-43.00
-0.16
-15.50
-55.41
-26.04
-41.55
-43.66
-96.58
-101.14
6.52
Net Fixed Assets
-11.49
6.36
-13.76
-37.00
43.97
-138.56
-83.89
-136.01
-3.33
90.14
Net Investments
-7.93
-0.06
11.72
-2.36
-0.04
58.91
3.87
32.73
-77.70
9.90
Others
-23.58
-6.46
-13.46
-16.05
-69.97
38.10
36.36
6.70
-20.11
-93.52
Cash from Financing Activity
-42.29
-50.87
-90.85
-41.38
-21.58
-1.14
-47.45
12.22
88.82
-12.11
Net Cash Inflow / Outflow
7.55
-10.12
-1.00
19.32
-4.17
19.90
-56.65
5.99
46.93
-3.67
Opening Cash & Equivalents
6.63
16.75
17.75
-1.61
2.29
-18.22
38.42
32.44
-14.50
-10.82
Closing Cash & Equivalent
14.18
6.63
16.75
17.75
-1.88
2.29
-18.22
38.42
32.44
-14.50

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
140.56
124.23
95.63
104.67
123.91
120.84
105.16
87.07
45.22
52.47
ROA
11.13%
12.85%
-4.01%
-7.63%
2.04%
6.56%
10.75%
25.73%
15.85%
-2.76%
ROE
18.36%
23.93%
-8.30%
-16.11%
4.27%
13.05%
21.92%
64.77%
40.79%
-6.00%
ROCE
21.99%
21.97%
1.58%
-5.25%
7.50%
12.62%
12.98%
40.16%
33.86%
1.96%
Fixed Asset Turnover
1.40
1.24
0.93
1.08
1.25
1.52
1.98
3.33
2.79
1.02
Receivable days
71.83
64.16
60.61
67.14
71.03
66.65
84.30
60.55
68.24
96.46
Inventory Days
95.93
82.04
118.27
151.04
147.34
140.69
134.72
62.62
54.27
73.67
Payable days
147.04
164.01
155.24
131.18
150.99
160.90
86.23
63.57
60.55
60.91
Cash Conversion Cycle
20.73
-17.81
23.64
87.00
67.38
46.44
132.79
59.60
61.95
109.22
Total Debt/Equity
0.27
0.30
0.48
0.72
0.66
0.66
0.73
0.87
1.39
0.60
Interest Cover
8.57
6.59
0.43
-1.40
2.50
3.72
3.16
7.06
6.57
0.45

News Update:


  • Fermenta Biotech - Quarterly Results
    12th Aug 2026, 00:00 AM

    Read More
  • Fermenta Biotech gets FSSAI’s approval for VITADEE Green
    6th Jul 2026, 09:19 AM

    It supports the broader national objective of addressing Vitamin D deficiency through food fortification, an area where regulators have increasingly favoured plant-based sources

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.